EP2094387A2 - Processeur automatique à microfluide - Google Patents
Processeur automatique à microfluideInfo
- Publication number
- EP2094387A2 EP2094387A2 EP07817739A EP07817739A EP2094387A2 EP 2094387 A2 EP2094387 A2 EP 2094387A2 EP 07817739 A EP07817739 A EP 07817739A EP 07817739 A EP07817739 A EP 07817739A EP 2094387 A2 EP2094387 A2 EP 2094387A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- microfluidic processor
- processor according
- temperature
- hydrogels
- pumps
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 claims abstract description 53
- 230000008569 process Effects 0.000 claims abstract description 35
- 230000004913 activation Effects 0.000 claims abstract description 8
- 238000013461 design Methods 0.000 claims abstract description 3
- 239000000017 hydrogel Substances 0.000 claims description 56
- 238000003752 polymerase chain reaction Methods 0.000 claims description 26
- 230000008961 swelling Effects 0.000 claims description 20
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 18
- 238000004458 analytical method Methods 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 15
- 230000004888 barrier function Effects 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 230000000694 effects Effects 0.000 claims description 12
- 229920000642 polymer Polymers 0.000 claims description 12
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 10
- 230000006870 function Effects 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 7
- 239000000499 gel Substances 0.000 claims description 6
- 238000012136 culture method Methods 0.000 claims description 4
- 230000002123 temporal effect Effects 0.000 claims description 4
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 239000011557 critical solution Substances 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 229920000936 Agarose Polymers 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims description 2
- 235000014593 oils and fats Nutrition 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000002195 soluble material Substances 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- 239000001993 wax Substances 0.000 claims description 2
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 claims 1
- IBDVWXAVKPRHCU-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl 3-oxobutanoate Chemical compound CC(=O)CC(=O)OCCOC(=O)C(C)=C IBDVWXAVKPRHCU-UHFFFAOYSA-N 0.000 claims 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims 1
- 230000003851 biochemical process Effects 0.000 claims 1
- 230000000903 blocking effect Effects 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 abstract description 5
- 208000003443 Unconsciousness Diseases 0.000 description 37
- 238000004519 manufacturing process Methods 0.000 description 14
- 239000000872 buffer Substances 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 9
- 239000004205 dimethyl polysiloxane Substances 0.000 description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000006399 behavior Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 238000012340 reverse transcriptase PCR Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 230000007704 transition Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 238000005086 pumping Methods 0.000 description 4
- 102100033072 DNA replication ATP-dependent helicase DNA2 Human genes 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 101000927313 Homo sapiens DNA replication ATP-dependent helicase DNA2 Proteins 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229920006037 cross link polymer Polymers 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 241000206602 Eukaryota Species 0.000 description 2
- 108010029541 Laccase Proteins 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000001311 chemical methods and process Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 150000001925 cycloalkenes Chemical class 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000004146 energy storage Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- -1 polydimethylsiloxane Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000005496 tempering Methods 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- ZTOJFFHGPLIVKC-UHFFFAOYSA-N 3-ethyl-2-[(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C1=NN=C1SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-UHFFFAOYSA-N 0.000 description 1
- 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- 241001622623 Coeliadinae Species 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 208000001490 Dengue Diseases 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 241000589242 Legionella pneumophila Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 241000589884 Treponema pallidum Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000606834 [Haemophilus] ducreyi Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 201000004308 chancroid Diseases 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- 239000005549 deoxyribonucleoside Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000003891 environmental analysis Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 208000028104 epidemic louse-borne typhus Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000012921 fluorescence analysis Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000002032 lab-on-a-chip Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229940115932 legionella pneumophila Drugs 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000010137 moulding (plastic) Methods 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000004204 optical analysis method Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000010399 physical interaction Effects 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 230000008646 thermal stress Effects 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 206010061393 typhus Diseases 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000004457 water analysis Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/50273—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the means or forces applied to move the fluids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/42—Static mixers in which the mixing is affected by moving the components jointly in changing directions, e.g. in tubes provided with baffles or obstructions
- B01F25/43—Mixing tubes, e.g. wherein the material is moved in a radial or partly reversed direction
- B01F25/433—Mixing tubes wherein the shape of the tube influences the mixing, e.g. mixing tubes with varying cross-section or provided with inwardly extending profiles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/42—Static mixers in which the mixing is affected by moving the components jointly in changing directions, e.g. in tubes provided with baffles or obstructions
- B01F25/43—Mixing tubes, e.g. wherein the material is moved in a radial or partly reversed direction
- B01F25/433—Mixing tubes wherein the shape of the tube influences the mixing, e.g. mixing tubes with varying cross-section or provided with inwardly extending profiles
- B01F25/4331—Mixers with bended, curved, coiled, wounded mixing tubes or comprising elements for bending the flow
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/30—Micromixers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502738—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by integrated valves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/10—Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0867—Multiple inlets and one sample wells, e.g. mixing, dilution
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/087—Multiple sequential chambers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0415—Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic
- B01L2400/0421—Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic electrophoretic flow
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0481—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure squeezing of channels or chambers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/06—Valves, specific forms thereof
- B01L2400/0633—Valves, specific forms thereof with moving parts
- B01L2400/0672—Swellable plugs
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/06—Valves, specific forms thereof
- B01L2400/0677—Valves, specific forms thereof phase change valves; Meltable, freezing, dissolvable plugs; Destructible barriers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
Definitions
- the invention relates to an automatic microfluidic processor with integrated active elements.
- microfluidic devices implement more or less complex biological, biochemical or chemical processes through the integration of functions, this is referred to as "microfluidic process pren” or “labs on a chip” (“LOC”), “micro labs” or “micro total analysis systems”. ⁇ TAS).
- the LOC concept offers many advantages.
- the reduction in the volumes of fluid allows analyzing 'small samples and economical use of reagents and samples, which are often valuable, rare, harmful or dangerous.
- higher throughputs can also be achieved because, owing to the small quantities, shorter preparation, mixing and reaction times are required with a minimized energy requirement. Due to lower system response times, process control can also be easier.
- LOC setups enable significant process rationalization by dramatically reducing process time, increasing throughput and reducing the amount of media required (subjects, analytes, reagents, auxiliary media).
- media for example, a drug, a drug, or a mixture thereof.
- they are also non-specialists allow performing complicated investigations to e last example policemen Oxhausmaschine 'or To give inspection bodies such as food inspectors quick access to important results.
- the typical structure of biological, biochemical or chemical processes includes the tasks of sample preparation, handling and reaction or analysis, each in specific forms and combinations.
- on-chip integration of sample preparation as well as reaction or analysis is mainly done.
- economic benefits resulting from the rationalization of these sub-processes have generally proved unsustainable.
- sample handling Because of their problematic on-chip integration, sample handling is currently performed manually or with some special equipment, such as diluters, syringe pumps, pipetting equipment, etc., outside of the chips. Due to their predominantly manual character, these activities are the number one source of error in practice.
- active fluidic elements based on solid-state actuators such as piezoactuators [US Pat. No. 5,224,843, US 2003/0143122] and shape memory actuators [US Pat. No. 5,659,171]
- piezoactuators US Pat. No. 5,224,843, US 2003/0143122
- shape memory actuators US Pat. No. 5,659,171
- a possible hybrid integration eg sticking of the elements to the LOC
- Transducer elements which are based on changes in the state of matter, can be integrated into the layout of the channel structure supports with sometimes minor interventions and are therefore usually compatible with the production process of the plastic molded parts of the channel structure support.
- fuses R. Pal et al., Anal. Chem. 16 (2004) 13, pp 3740-3748
- freezing elements US 6,536,476
- thermal bubble generators US 6,283,718.
- Transducers with gas formation are not suitable for many microfluidic processes because most are sensitive to gas bubbles.
- the object of the invention is to provide a LOC device create, which can be produced with an economically justifiable manufacturing effort and which automatically performs certain chemical, biochemical or other processes, in particular standard processes.
- the basic idea of the invention is to use the microfluidic processor to perform all necessary active process steps essentially automatically and in a chronologically, qualitatively and quantitatively predefined order. without auxiliary power. to work off ' .
- the steps that require the performance of mechanical work are automatically performed by devices based on actuator or strength changes of certain materials.
- These components are defined in their basic functions, the temporal and aktoris'chen behavior and connected together to the corresponding logical functions.
- the process By largely dispensing with auxiliary energy, an automatic process sequence, a pre-assembly with necessary materials (eg analytes, reagents, auxiliary media) as well as an easily manageable size of the LOC, the process essentially runs independently of the user in the quality predefined by the LOC production and can be done almost anywhere.
- the user activity is limited to the sample introduction, the process start and possibly the reading of the result. Therefore, the LOCs of the invention also allow non-professionals to carry out complicated investigations. Since the LOC abutments are very simple and based on less materials (usually 'polymers), they can be cost-effective be manufactured and used as disposable products.
- the material basis of the invention are materials which can cause active functions by changes in their swelling state or their mechanical properties (strength, viscosity) and which can be activated with readily realizable environmental parameters.
- Particularly easily influenced environmental variables are the presence of solvents and the temperature, which are therefore of particular importance for the invention.
- Substances which can be influenced by the effect of temperature in their strength or viscous properties are, for example, oils and fats, waxes, paraffins or alkanes.
- Semi-solid paraffins or soft paraffin for example, have melting temperatures between 45 ° C and 65 0 C
- Petrolatum or petrolatum have melting temperatures in the range of 38 ° C and 60 0 C.
- soluble materials which may be, for example uncrosslinked polymers, salts and organic natural products such as saccharides.
- Hydrogels can be influenced both by temperature and by solvents. Due to the variety of functions that can be realized with these materials, the invention will be explained essentially in terms of hydrogels, representative of the other materials.
- Hydrogels are polymer networks that change their volume, strength and other properties when exposed to aqueous swelling agents. These polymer networks can be subdivided into chemically and physically crosslinked polymer networks or hydrogels according to the type of polymer chain linkage. For chemically crosslinked polymer mesh The individual polymer chains are irreversibly linked by covalent (chemical) compounds. In physically networked polymer networks, the polymer chains are interconnected by physical interactions, which can usually be resolved again.
- hydrogels When hydrogels swell from the dry or swollen state, they not only change their volume, but can simultaneously perform mechanical work by applying a swelling pressure. These swelling properties have physically and chemically crosslinked hydrogels. Certain chemically crosslinked hydrogels, the so-called stimuli-responsive hydrogels, can also be reversibly converted back into the swollen state when certain environmental variables are applied. This property is based on its volume phase transition behavior. Particularly interesting are temperature-sensitive hydrogels, such as poly (N-isopropylacrylamide) and poly (methyl vinyl ether), which can also be "light-sensitive" by appropriate absorption. Most temperature-sensitive stimuli-responsive hydrogels have a Lower Critical Solution Temperature (LCST).
- LCST Critical Solution Temperature
- the best known hydrogel 'with LCST characteristic poly ( ⁇ 7-isopropylacrylamide) (PNIPAAm), has a volume phase transition temperature of 32.8 0 C.
- the position of the phase transition or switching temperature of NIPAAm-based hydrogels can be adjusted by copolymerization and variation of the synthesis parameters in a range from +5 0 C to about 60 ° C.
- Possible synthesis and structuring methods of PNIPAAm-based hydrogels are for example in [A. Richter et al., J. Microelectromech., Syst., 12 (2003) 5, p. 748-753].
- Physically crosslinked hydrogels can also be temperature-sensitive. Such "thermoreversible” gels have a sol-gel transition behavior, ie they gel (crosslink) on reaching critical temperatures or dissolve by dewetting
- Typical temperature-switchable physically crosslinkable hydrogels are, for example, gelatin, pectin and agarose -Übergangstemperatureh can be through various measures between about 15 0 C and 95 0 C set. these and other physically crosslinked polymer networks has [K. te Nijenhuis, Thermoreversible networks, Adv. Polym. Sci. 130, Springer-Verlag, Berlin, Heidelberg, New York 1997].
- the time behavior of active hydrogel-based elements can be influenced by appropriate choice of the synthesis and crosslinking parameters (ultimately by the choice of the hydrogel), by limitations of the swelling agent supply and by forces which counteract the swelling process. It is particularly easy to implement restrictions on the swelling agent feed. This can be done by setting a corresponding flow resistance, for example by choosing a corresponding effective flow cross-section over a material porosity. In this case, the source process is slowed down.
- a time delay of the onset of the swelling process can be achieved by the use of swelling agent barriers, which dissolve after certain periods. The delay time can be defined by varying the layer thickness as well as by material selection. Typical materials for swelling agent or diffusion barriers are saccharides.
- hydrogels over other transducers is the enormous variety of active functions. which can be realized with them. They can be used as active fluidic elements in the form of switching elements, fluidic drives, recording and dispensing systems of active substances and other substances, but also for enclosing / fixing or releasing objects (for example by gelling or dissolving). Another advantage of this effect carrier is their ease of manufacture. Hydrogels as plastics can be realized with the typical procedures for this class of substances. Since most functional elements also have the same or similar basic structures, the active hydrogel elements can be produced directly on the channel structure carriers with one or only a few additional manufacturing steps.
- FIG. 1 shows the circuit diagram of the channel structure carrier of an automatic hydrogel-based microfluidic processor which, for example, can be used in the control of bioreactors on the basis of the expression level of selected growth markers,
- FIGS. 4a to 4c show the basic mode of operation of a time-controlled and event-controlled valve based on a thermostable physical polymer network; 5a and 5b show the mode of operation of a drug delivery unit based on a soluble element,
- Figure 7 is a possible circuit diagram of a LOC setup for standard biochemical and medical applications based on polymerase chain reactions
- FIGS. 4 to 6 illustrate the mode of operation of some automatic active hydrogel elements.
- FIG. 7 demonstrates further typical applications of the LOC according to the invention.
- the circuit diagram of an LOC channel structure shown in FIG. 1 is suitable for a whole range of chemical, biotechnological and standard medical applications. Its functionality is explained by the determination of the enzyme activity (laccase activity) of a bioreactor.
- Two pumps Ia and Ib contain 0.05M malonate buffer of pH 5.0.
- a further pump Ic contains a 2mM 2, 2 '-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) solution as substrate in a 0.05M malonate buffer of pH 5.0.
- ABTS 2mM 2, 2 '-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid)
- Id is a sample of a bioreactor product laccase, which z. B. was removed from the current reactor operation.
- the buffer and substrate (pump Ia with pump Ic) and buffer and sample (pump Ib with pump Id) are mixed by mixing meanders 4a, 4b and distributed to pumps 2a to 2f, wherein in the pumps 2a to 2c respectively a buffer sample mixture and in the pumps 2d to 2f a buffer substrate mixture is presented.
- the pumps Ia-Id and 2a-2f can each have on the output side valves not shown in detail, which close at concern of the liquid (which is the case with completely filled pump chamber) and later open again at the onset of pumping activity.
- the buffer substrate and buffer sample are mixed by further mixing meanders 4c to 4e and mixed in Reaction and analysis units 3a to 3c transported.
- the enzyme reaction can be followed by optical analysis methods.
- the simplest optical analysis unit can be a light-dependent resistor (LDR), not shown in detail, which gives a simple yes-no response (enzyme activity present or absent).
- Enzyme kinetic parameters can be determined by light-spectroscopic methods (eg UV-VIS spectroscopy).
- the basic media such as buffer and substrate can be incorporated in a final manufacturing step in LOC production. After proper storage, the user only needs to put the sample into the LOC and to activate. The entire procedure then runs automatically.
- the four-layer structure consists of a channel structure carrier 8, which is covered by an at least locally flexible membrane 9. Above this is the actuator structure carrier 10, which contains a large part of the active hydrogel elements 14. Above the Aktor Stevenisme 10 is a structural support 11, which carries the components 12, 15, with which the time sequence and the 'time behavior of the active hydrogel elements 14 are set.
- microfluidic processors can be carried out for the structural supports 8, 10, 11 using the customary methods of mass production of plastic moldings, such as injection molding, hot stamping or the like. Suitable materials are those customary for microfluidics, z.
- PC polycarbonate
- COC cycloolefins
- PA polyamides
- PET polyester
- PS polystyrene
- PS polyvinyl chloride
- PDMS polydimethylsiloxane
- PMMA polymethylmethacrylate
- PTFE polytetrafluoroethylene
- a very simple variant for the production of small series is the Mas ter terformen of PDMS.
- negative structures of the structural supports 8, 10, 11 are produced photolithographically in silicon wafers and these are subsequently coated with Teflon by sputtering in order to obtain good moldability. Thereafter, the PDMS is placed on the molds and cured for one hour at 100 0 C.
- the flexible membranes 9 can also be produced in PDMS by spin coating. The layer thicknesses can be adjusted very well with this method between about 15 microns to 100 microns. Films of the required thicknesses can also be purchased commercially.
- the individual layers of the LOC can be glued together, welded or non-positively joined.
- PDMS moldings can be bonded very well with PDMS as an adhesive and subsequent temperature hardening.
- the active hydrogel elements 14 can be produced by various methods. For structuring hydrogel layers, crosslinking photopolymerization and photocrosslinking [A. Richter et al. , J. Microelectromech. Syst. 12 (2003) 5, pp 748-753] used '. Furthermore, the molding with subsequent polymerization and the production of hydrogel particles [K. -F. Arndt et al. , Polym. ⁇ DV. Technol. 11 (2000), pp. 496-505].
- the 2 shows a LOC section with two active hydrogel elements 14a, 14b, by means of which the basic mode of operation of the LOC according to the invention can be described.
- the hydrogel elements 14a, 14b perform their task by expansion as a result of swelling in the channel structure of the structural support 8.
- the swelling agent necessary for this they take on the structural support 11.
- the structural support 11 contains structural elements which make it possible to determine the temporal behavior of the hydrogel elements 14.
- the swelling agent barriers 15a, 15b determine the point in time at which the swelling agent can reach the hydrogel element 14. For example, if the diffusion barriers are made of the same material, but 15b is thinner than 15a, then 15b will have dissolved faster than 15a, and that Hydrogel element 14b begins to act before 14a.
- the semi-permeable walls 12a and 12b serve the hydrogel elements 14 as a fixed bearing; on the other hand, the maximum possible volume expansion of the elements 14 per unit of time can also be defined by varying the effective supply cross-section.
- the arrangement can serve as a sample receiving unit, for example.
- the pump chamber 13 Via the side of the element 14b, the pump chamber 13 can be filled with sample liquid.
- the diffusion barrier 15b is dissolved, so that the swelling agent reaches the hydrogel element 14b and swells it.
- 14b seals the channel structure as a result of the deflection of the membrane 9.
- the element 14a displaces via the flexible membrane 9 the liquid from the pump chamber 13 of the structural support 8 in the direction of the unclosed exit.
- FIG. 3 shows a valve which is initially actuated, then time-controlled.
- a common task is to seal a memory or channel structure of a LOC after it has been completely filled with the process medium. If the medium located in the channel 16 reaches the unswollen hydrogel actuator 17a (FIG. 3a), it begins to swell while receiving the sample medium until it has completely closed the channel structure 16 (swollen hydrogel actuator 17b in FIG. 3b).
- the absorption of the process medium by 17b due to its swelling can be done so quickly that no Medium can flow past the valve seat.
- the opening process of the valve is timed. As illustrated in FIG. 3c, after the preset time, the barrier layer 15 is dissolved or impaired in its strength in such a way that the flexible membrane 9 can deflect on the valve seat and thus open the valve seat.
- Adequate results can be achieved with a variety of mechanisms based on the change in the degree of swelling, the strength or viscosity or the crosslinking properties of the functional elements. • Of course, it is also possible that certain components are triggered multiple times only time or only event-dependent '.
- thermoreversible physical polymer network As material is here. used a thermoreversible physical polymer network, while serving as the opening process triggering the temperature.
- the process medium 19 encounters the unswollen hydrogel actuator 17a (see FIG. 4a) within the channel 16, then it swells while receiving the process medium 19 until it completely closes off the channel 16 (FIG. 4b). After reaching a certain temperature (this can be realized depending on the event or time), the physical polymer network wears off and dissolves (17c in FIG. 4c). Thus, the channel 16 is unlocked and the medium can be transported on. This temperature may also be caused by fever or inflammation.
- Fig. 5 illustrates a device that can deliver drugs.
- an active substance 20 which is gelled in a matrix Hydrogel 17d is included (Fig. 5a).
- Channel structure carrier 8 and the chamber with 17d and 20 is covered by an elastic film, which is biased over the chamber and therefore serves as a spring energy storage.
- the gelled hydrogel 17d may be thermoreversible.
- the active substance 20 is released when the gelation temperature of the hydrogel is reached and it dissolves (17c in FIG. 5b).
- the spring force accumulator 21 discharges and pushes the dissolved substances out of the chamber through the outlet 6.
- Fig. 6 shows that an activation of spring force storage by a programming unit 11 is easily possible.
- a prestressed spring energy accumulator 21 is locked in this position by a barrier layer 15 (FIG. 6a). If the barrier layer 15 dissolved by solvent presence or reduced in strength, the spring force accumulator can be discharged by turning into the chamber 13 and displaces the medium located there ( Figure 6b).
- the time-dependent, but also event-dependent, control of the LOC processes can take place in addition to the presence of the swelling agent, also by changing the ambient or LOC temperature.
- the controlling acting temperature are steadily increased with a defined heating rate.
- the individual components have different activation temperatures (for example, gelling temperature, phase transition temperature), they are activated in a corresponding temperature graduated order.
- the kinetics can also be influenced in terms of the speed with which the property-changing processes take place.
- the order of components with the same activation temperature can be done by a corresponding thermal dimensioning of the LOC structure by acting as a series resistors thermal resistance (variation of thermal conductivity, material thickness, etc.) and the heat capacities are set.
- tempering devices have to be used anyway, as is the case, for example, with polymerase chain reactions (PCR).
- PCR polymerase chain reactions
- the required components can be controlled with a short heating power increase by the PCR tempering unit.
- Such devices may, for example, appropriately modified PCR thermal devices, thermostats, thermal cycler heat cabinets ⁇ or heat baths to be capable of realizing a predetermined temperature programs.
- nucleic acid amplification assays such as PCR
- PCR nucleic acid amplification assays
- FIG. 7 shows the circuit diagram of a LOC setup for standard biochemical and medical applications based on polymerase chain reactions.
- the master mix may, for example, have the following composition:
- the H 2 O can also be proportionally substituted by additives such as DMSO, glycerol and others (eg at high GC content).
- the volume information for the master mix is multiplied by the number of applications.
- the thus prepared master mix, in a refrigerated storage vessel (4 0 C) are provided outside the LOC. The same applies to the template DNA's.
- the pumps If and Ig are each loaded with 10 ⁇ l of a master mix.
- pump Ih are lO ⁇ l template DNAl (plasmid, about 100 ng in H 2 O - molecular biology grade) for the PCR control reaction.
- Pump Ie contains 10 ⁇ l template DNA2 (plasmid, ca. 100 ⁇ g in H 2 O - molecular biology grade) for the PCR reaction.
- the PCR products can also be removed at the output 10a or output 10b for external further processing.
- the PCR products in the chambers 24a and 24b are separated electrophoretically and can be provided at the output 10c or output 10d, for example for the external fluorescence analysis become.
- 11 again denotes the entrances to the pump chambers Ie-Ih.
- RT-PCR reverse transcriptase PCR
- the basic composition of an RT master mix for a two-step RT-PCR method shows the following example:
- RNA or mRNA prokaryotic or eukaryotic
- target sequence reverse transcriptase s
- t oligo (dT) primer alternatively: sequence-specific or random-hexamer primer
- the cDNA synthesis takes place at 37 0 C to 50 0 C.
- Fig. 8 shows a LOC structure with which microorganisms can be easily identified or excluded simply by the culture method.
- a smear stick is inserted via the sample channel 28 into the sterile sample receiving chamber 27. There, the swab is stripped so that existing microorganisms remain in 27.
- the pump 25 is activated by a mechanism, not shown, so that the culture medium flows through the channel 26 with entrainment of the Abstrichgutes in the Analyshimmmern 29 a to 29 c.
- the analysis chambers 29 are selective culture media that promote the growth of certain organisms or inhibit or change their properties due to their composition depending on the growing microorganisms their properties (eg dyeing). After a specified time, cultures or colorings grown on a positive test are visible and can be read by the user.
- the inscription 30 serves the user for unambiguous assignment of the analysis result.
- smears for the differentiation of fungal and bacterial infections.
- An enhanced differentiation is useful, for example in the case of frequently occurring disease classes, such as sexually transmitted tagbare diseases STI (sexually transmitted infections) such as gonorrhea ⁇ Neisser ⁇ a gonorrhoeae), syphilis (Treponema pallidum), chancroid ⁇ Haemophilus ducreyi) ', chlamydia (Chlamydia trachomatis) or regionally typical diseases (eg malaria, hepatitis, HIV, typhus, measles, influenza, dengue).
- STI sexually transmitted tagbare diseases
- gonorrhea ⁇ Neisser ⁇ a gonorrhoeae syphilis
- chancroid ⁇ Haemophilus ducreyi
- chlamydia Cholamydia trachomatis
- regionally typical diseases eg malaria, he
- Escherichia coli can be detected in toilets, hospital beds, showers, etc. Also microbial contamination of food and environment, for example Legionella (Legionella pneu- mophila) in drinking water or salmonella in food, can be easily detected with the LOC.
- Legionella Legionella pneu- mophila
- the described examples represent a multiplicity of possible further applications of the microfluidic processors according to the invention.
- the processor architecture eg additional pumps, mixing chambers, reaction chambers, etc.
- Even more complex processes can be realized on one LOC.
- It can be miniaturized and automated manifold pipetting and analysis tasks, which not only causes a significant cost and time reduction, but also the process quality z. B. significantly improved by reducing the pipetting error.
- the LOCs are preferably suitable for one-off (disposable) procedures, but can be used with appropriate execution, but also for continuous or online tasks. Due to the miniaturization and automation a ' mobile, (energy-) self-sufficient and location-independent use of the LOCs is possible. With well observable property changes, no additional analysis or reading units are required.
- B. Microorganism analyzes by identifying and assigning an activity profile, but also Sehnelltests to determine the water quality [CSB (chemical oxygen demand), BOD (biological oxygen demand), heavy metals, nitrate, nitrite, etc.] realize.
- CSB chemical oxygen demand
- BOD biological oxygen demand
- heavy metals nitrate, nitrite, etc.
- the LOC technology according to the invention can be used, for example, for cell culture control (eukaryotes, human cell lines, etc.) by viability tests [eg WST-I and MTT test (conversion of a tetrazolium salt into formazan, eg 4- [3- (4-iodophenyl ) - 2- (4-nitrophenyl) -2H-5-tetrazolium] -1,3-benzenedisulfonate) or LDH test (lactate dehydrogenase test)], etc.
- viability tests eg WST-I and MTT test (conversion of a tetrazolium salt into formazan, eg 4- [3- (4-iodophenyl ) - 2- (4-nitrophenyl) -2H-5-tetrazolium] -1,3-benzenedisulfonate) or LDH test (lactate dehydrogenase test)], etc.
- On-chip blood tests to determine part of the most important blood parameters eg blood sugar, pH, lactate, minerals, creatine, hormones, enzymes, leukocytes, erythrocytes, etc., disease markers, the detection of reactive Oxigeh-Toxic substances (ROTS oxidative stress) etc. are feasible.
- ROTS oxidative stress reactive Oxigeh-Toxic substances
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Clinical Laboratory Science (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Saccharide Compounds (AREA)
Abstract
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006051535A DE102006051535A1 (de) | 2006-10-27 | 2006-10-27 | Automatischer Mikrofluidik-Prozessor |
| PCT/DE2007/001905 WO2008049413A2 (fr) | 2006-10-27 | 2007-10-23 | Processeur automatique à microfluide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2094387A2 true EP2094387A2 (fr) | 2009-09-02 |
Family
ID=39267935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP07817739A Withdrawn EP2094387A2 (fr) | 2006-10-27 | 2007-10-23 | Processeur automatique à microfluide |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9029131B2 (fr) |
| EP (1) | EP2094387A2 (fr) |
| DE (2) | DE102006051535A1 (fr) |
| WO (1) | WO2008049413A2 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8551599B2 (en) | 2008-09-03 | 2013-10-08 | The Regents Of The University Of Michigan | Reconfigurable microactuator and method of configuring same |
| CN102859616B (zh) | 2010-04-09 | 2015-05-20 | 香港科技大学 | 液体-电子混合式分压器 |
| DE102010015161B4 (de) | 2010-04-16 | 2014-03-13 | Technische Universität Dresden | Mikrofluidiksystem und Verfahren zu dessen Betreiben |
| KR20120091631A (ko) * | 2011-02-09 | 2012-08-20 | 삼성전자주식회사 | 미세유동장치 |
| KR101257700B1 (ko) * | 2011-12-05 | 2013-04-24 | 삼성전자주식회사 | 미세유동장치 및 이를 포함하는 미세유동시스템 |
| FR2987282B1 (fr) * | 2012-02-24 | 2017-12-29 | Fonds De L'espci Georges Charpak | Microcanal avec dispositif d'ouverture et/ou fermeture et/ou pompage |
| DE102012206042B4 (de) | 2012-04-13 | 2013-11-07 | Technische Universität Dresden | Verfahren und Vorrichtung zur gezielten Prozessführung in einem Mikrofluidik-Prozessor mit integrierten aktiven Elementen |
| JP2014240065A (ja) * | 2013-05-15 | 2014-12-25 | 公立大学法人大阪府立大学 | 流路構造体および流路構造体の製造方法 |
| CN108495712A (zh) | 2015-11-23 | 2018-09-04 | 伯克利之光生命科技公司 | 原位生成的微流体隔离结构、试剂盒及其使用方法 |
| CN111420718B (zh) * | 2020-04-01 | 2022-01-14 | 安徽大学 | 一种求解最小集合覆盖问题的微流控芯片及其dna计算方法 |
| DE102023129147A1 (de) | 2023-10-24 | 2025-04-24 | Technische Universität Dresden, Körperschaft des öffentlichen Rechts | Fluidische Vorrichtung und Verfahren zur Probenvorbereitung mit einer fluidischen Vorrichtung |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990015929A1 (fr) | 1989-06-14 | 1990-12-27 | Westonbridge International Limited | Micropompe perfectionnee |
| US5659171A (en) | 1993-09-22 | 1997-08-19 | Northrop Grumman Corporation | Micro-miniature diaphragm pump for the low pressure pumping of gases |
| DE19812436A1 (de) | 1998-03-22 | 1999-09-30 | Univ Dresden Tech | Funktionselement für die Fluid- oder Aerosoltechnik |
| US6375901B1 (en) | 1998-06-29 | 2002-04-23 | Agilent Technologies, Inc. | Chemico-mechanical microvalve and devices comprising the same |
| US6283718B1 (en) | 1999-01-28 | 2001-09-04 | John Hopkins University | Bubble based micropump |
| WO2001007506A2 (fr) * | 1999-07-23 | 2001-02-01 | The Board Of Trustees Of The University Of Illinois | Dispositifs microfabriques et leur procede de fabrication |
| JP3548858B2 (ja) | 2001-01-22 | 2004-07-28 | 独立行政法人産業技術総合研究所 | 流量の制御方法及びそれに用いるマイクロバルブ |
| US7988685B2 (en) | 2001-11-01 | 2011-08-02 | Regents Of The University Of Minnesota | Hydrogel compositions, devices, and microscale components |
| DE10157317A1 (de) | 2001-11-23 | 2003-06-05 | Gesim Ges Fuer Silizium Mikros | Grundelement eines Mikrofluidik-Prozessors |
| DE10202996A1 (de) | 2002-01-26 | 2003-08-14 | Eppendorf Ag | Piezoelektrisch steuerbare Mikrofluidaktorik |
| AU2003285849A1 (en) * | 2002-03-20 | 2004-03-29 | Advanced Sensor Technologies, Inc. | Personal monitor to detect exposure to toxic agents |
| US7648619B2 (en) * | 2002-06-04 | 2010-01-19 | Industrial Technology Research | Hydrogel-driven micropump |
| DE10300896A1 (de) | 2003-01-13 | 2004-07-22 | Disetronic Licensing Ag | Automatische, von Hydrogelen getriebene Fördereinrichtung mit einstellbarer Abgabecharakteristik zum Fördern eines Mediums, insbesondere Insulin |
| JP4784508B2 (ja) * | 2004-05-07 | 2011-10-05 | コニカミノルタエムジー株式会社 | 検査用マイクロリアクタおよび検査装置ならびに検査方法 |
| DE102004062893A1 (de) | 2004-12-20 | 2006-06-29 | Technische Universität Dresden | Elektronisch steuerbare Mikropumpe auf Hydrogelbasis |
| US8337777B2 (en) * | 2006-06-28 | 2012-12-25 | Applied Biosystems, Llc | Sample distribution devices and methods |
-
2006
- 2006-10-27 DE DE102006051535A patent/DE102006051535A1/de not_active Withdrawn
-
2007
- 2007-10-23 WO PCT/DE2007/001905 patent/WO2008049413A2/fr not_active Ceased
- 2007-10-23 DE DE112007003160.3T patent/DE112007003160B4/de not_active Expired - Fee Related
- 2007-10-23 EP EP07817739A patent/EP2094387A2/fr not_active Withdrawn
- 2007-10-23 US US12/446,979 patent/US9029131B2/en active Active
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2008049413A2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008049413A2 (fr) | 2008-05-02 |
| DE112007003160B4 (de) | 2023-02-09 |
| US9029131B2 (en) | 2015-05-12 |
| DE112007003160A5 (de) | 2009-09-24 |
| DE102006051535A1 (de) | 2008-12-18 |
| US20100151561A1 (en) | 2010-06-17 |
| WO2008049413A3 (fr) | 2008-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE112007003160B4 (de) | Automatischer Mikrofluidik-Prozessor | |
| DE102012206042B4 (de) | Verfahren und Vorrichtung zur gezielten Prozessführung in einem Mikrofluidik-Prozessor mit integrierten aktiven Elementen | |
| EP1252929B1 (fr) | Ensemble des biopuces | |
| WO2009080817A2 (fr) | Système de test rapide mobile pour analyse d'acide nucléique | |
| DE102010015161B4 (de) | Mikrofluidiksystem und Verfahren zu dessen Betreiben | |
| DE102009001257A1 (de) | Vorrichtung und Verfahren zur Handhabung von Flüssigkeiten | |
| DE102006020716B4 (de) | Mikrofluidik-Prozessor | |
| DE19917327C2 (de) | Dosiervorrichtung und Verfahren zur Dosierung und zum Transfer von kleinen Mengen eines Fluids | |
| EP2525225A1 (fr) | Installation et procédé d'analyse de la différentiation de cellules | |
| WO2004000463A1 (fr) | Dispositif de manipulation de liquides dans une pluralite de canaux | |
| JP6084370B2 (ja) | 組織化学用自動反応装置 | |
| DE102005049976A1 (de) | Anordnung zur integrierten und automatisierten DNA- oder Protein-Analyse in einer einmal verwendbaren Cartridge, Herstellungsverfahren für eine solche Cartridge und Betriebsverfahren der DNA- oder Protein-Analyse unter Verwendung einer solchen Cartridge | |
| EP3094740B1 (fr) | Unité d'analyse permettant la réalisation d'une amplification en chaîne par polymérase nichée, dispositif d'analyse, procédé pour faire fonctionner une telle unité d'analyse et procédé de fabrication d'une telle unité d'analyse | |
| DE102004061731A1 (de) | Programmierbarer Mikrostempel auf Hydrogelbasis | |
| Yu et al. | Miniaturized PCR-chip for DNA amplification with an external peristaltic pump | |
| DE102004061732B4 (de) | Steuerbare Einrichtung aus mehreren Einzelspeicherzellen auf Hydrogelbasis | |
| DE102007009806A1 (de) | Flüssigkeitshandhabungssystem | |
| DE102021212645B4 (de) | Vorrichtung und Verfahren zur Durchführung mikrofluidischer Prozessschritte | |
| DE102006053451B4 (de) | Mikrofluidische Plattform zur Temperierung von Substanzen und/oder zur Durchführung von zu temperierenden Reaktionen | |
| EP4545180A1 (fr) | Dispositif fluidique et procédé de préparation d'échantillon à l'aide d'un dispositif fluidique | |
| WO2003106032A1 (fr) | Chambre d'hybridation | |
| DE10203211A1 (de) | Mikrofluidikprobenmodul mit Mitteln zur Temperaturbeeinflussung | |
| EP2739967A1 (fr) | Élément de chromatographie à circulation latérale | |
| DE102010028012A1 (de) | Flüssigkeitssteuerung für Mikrodurchflusssystem | |
| DE202018006869U1 (de) | Mikrofluidisches System für die digitale Polymerasekettenreaktion (dPCR) einer biologischen Probe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20090515 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
| DAX | Request for extension of the european patent (deleted) | ||
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: WAGE, TOBIAS Inventor name: KLATT, STEPHAN Inventor name: RICHTER, ANDREAS |
|
| 17Q | First examination report despatched |
Effective date: 20110721 |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: TECHNISCHE UNIVERSITAET DRESDEN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20161125 |